Tirzepatide · 1 matching version
NCT07693608
Matching submitted history spans August 19, 2026 to August 19, 2026.
Open complete source-attributed timeline →Status at public version
176 public ClinicalTrials.gov history versions across 39 trial records carrying the source-declared Enrolling By Invitation status. The status belongs to each cited historical version and may not describe the registry today.
Tirzepatide · 1 matching version
Matching submitted history spans August 19, 2026 to August 19, 2026.
Open complete source-attributed timeline →Setmelanotide · 1 matching version
Matching submitted history spans July 22, 2026 to July 22, 2026.
Open complete source-attributed timeline →Abaloparatide · 1 matching version
Matching submitted history spans July 22, 2026 to July 22, 2026.
Open complete source-attributed timeline →Tirzepatide · 2 matching versions
Matching submitted history spans July 12, 2026 to July 16, 2026.
Open complete source-attributed timeline →Semaglutide · 3 matching versions
Matching submitted history spans April 1, 2025 to June 30, 2026.
Open complete source-attributed timeline →Teriparatide · 4 matching versions
Matching submitted history spans February 9, 2024 to March 27, 2026.
Open complete source-attributed timeline →Semaglutide · 1 matching version
Matching submitted history spans December 10, 2025 to December 10, 2025.
Open complete source-attributed timeline →Tirzepatide · 1 matching version
Matching submitted history spans November 12, 2025 to November 12, 2025.
Open complete source-attributed timeline →Semaglutide · 13 matching versions
Matching submitted history spans July 2, 2024 to October 27, 2025.
Open complete source-attributed timeline →Tirzepatide · 1 matching version
Matching submitted history spans October 23, 2025 to October 23, 2025.
Open complete source-attributed timeline →Setmelanotide · 5 matching versions
Matching submitted history spans September 13, 2024 to September 2, 2025.
Open complete source-attributed timeline →Vosoritide · 1 matching version
Matching submitted history spans July 9, 2025 to July 9, 2025.
Open complete source-attributed timeline →Semaglutide · 1 matching version
Matching submitted history spans June 4, 2025 to June 4, 2025.
Open complete source-attributed timeline →Semaglutide · 1 matching version
Matching submitted history spans May 5, 2025 to May 5, 2025.
Open complete source-attributed timeline →Vosoritide · 2 matching versions
Matching submitted history spans June 7, 2024 to March 17, 2025.
Open complete source-attributed timeline →Setmelanotide · 8 matching versions
Matching submitted history spans January 2, 2024 to January 6, 2025.
Open complete source-attributed timeline →Liraglutide · 3 matching versions
Matching submitted history spans April 1, 2024 to May 16, 2024.
Open complete source-attributed timeline →Glucagon · 1 matching version
Matching submitted history spans February 9, 2024 to February 9, 2024.
Open complete source-attributed timeline →Semaglutide · 69 matching versions
Matching submitted history spans July 31, 2020 to November 21, 2023.
Open complete source-attributed timeline →Semaglutide · 4 matching versions
Matching submitted history spans March 25, 2022 to September 28, 2023.
Open complete source-attributed timeline →Semaglutide · 1 matching version
Matching submitted history spans April 26, 2023 to April 26, 2023.
Open complete source-attributed timeline →Setmelanotide · 3 matching versions
Matching submitted history spans December 6, 2022 to April 4, 2023.
Open complete source-attributed timeline →Teriparatide · 1 matching version
Matching submitted history spans February 9, 2023 to February 9, 2023.
Open complete source-attributed timeline →Liraglutide · 1 matching version
Matching submitted history spans December 15, 2021 to December 15, 2021.
Open complete source-attributed timeline →Liraglutide · 2 matching versions
Matching submitted history spans April 20, 2020 to April 27, 2021.
Open complete source-attributed timeline →Octreotide · 2 matching versions
Matching submitted history spans November 6, 2018 to March 25, 2020.
Open complete source-attributed timeline →Liraglutide · 16 matching versions
Matching submitted history spans December 6, 2016 to February 4, 2019.
Open complete source-attributed timeline →Liraglutide · 7 matching versions
Matching submitted history spans December 17, 2014 to June 22, 2017.
Open complete source-attributed timeline →Vosoritide · 2 matching versions
Matching submitted history spans March 25, 2016 to June 8, 2017.
Open complete source-attributed timeline →Octreotide · 2 matching versions
Matching submitted history spans September 26, 2016 to September 27, 2016.
Open complete source-attributed timeline →Octreotide · 3 matching versions
Matching submitted history spans March 5, 2015 to February 9, 2016.
Open complete source-attributed timeline →Octreotide · 3 matching versions
Matching submitted history spans March 5, 2015 to February 9, 2016.
Open complete source-attributed timeline →Lixisenatide · 1 matching version
Matching submitted history spans December 21, 2015 to December 21, 2015.
Open complete source-attributed timeline →Liraglutide · 2 matching versions
Matching submitted history spans November 28, 2012 to September 30, 2014.
Open complete source-attributed timeline →Exenatide · 1 matching version
Matching submitted history spans June 10, 2014 to June 10, 2014.
Open complete source-attributed timeline →Teriparatide · 1 matching version
Matching submitted history spans December 23, 2013 to December 23, 2013.
Open complete source-attributed timeline →Octreotide · 2 matching versions
Matching submitted history spans June 10, 2013 to June 14, 2013.
Open complete source-attributed timeline →Teriparatide · 2 matching versions
Matching submitted history spans May 24, 2011 to May 25, 2011.
Open complete source-attributed timeline →Leuprolide · 1 matching version
Matching submitted history spans October 5, 2010 to October 5, 2010.
Open complete source-attributed timeline →